Differences

This shows you the differences between two versions of the page.

--- jeremy_grimshaw [2022/05/09 07:51]
liam [Diabetes]
+++ jeremy_grimshaw [2022/05/09 08:23] (current)
liam [Antimicrobial Resistance]
@@ Line 32: / Line 32: @@
 Grimshaw is a Senior Scientist in the Clinical Epidemiology Program at the [[Ottawa Hospital Research Institute]].((//Jeremy Grimshaw.// Ottawa Hospital Research Institute. Retrieved May 8, 2022, from http://www.ohri.ca/profile/jgrimshaw))
-==== Ireland Canada University Foundation ====
+==== Eastern Ontario Regional Laboratory Association ====
-Grimshaw
+Grimshaw sits on the board of directors at the [[Eastern Ontario Regional Laboratory Association]].((//Board of Directors.// Eastern Ontario Regional Laboratory Association. Retrieved May 8, 2022, from https://archive.ph/dHgGJ))
 ==== AcademyHealth ====
@@ Line 50: / Line 50: @@
 ==== COVID-19 ====
-Grimshaw is a co-Principal Investigator of the [[COVID-END]] study, funded by the [[Canadian Institutes of Health Research]] (CIHR).((Grimshaw, J. (2021). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://web.archive.org/web/20220508082748/https://covid19-sciencetable.ca/wp-content/uploads/2021/02/Declaration-of-Interest_Behavioural-Science-Working-Group_Jeremy-Grimshaw_20210513.pdf)) He is also a member of the Canadian secretariat.((//Secretariat.// (2021). McMaster Health Forum. https://www.mcmasterforum.org/networks/covid-end/resources-specific-to-canada/about-us/secretariat))
+Grimshaw is a co-Principal Investigator and co-Chair of the [[COVID-END]] study, funded by the [[Canadian Institutes of Health Research]] (CIHR).((Grimshaw, J. (2021). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://web.archive.org/web/20220508082748/https://covid19-sciencetable.ca/wp-content/uploads/2021/02/Declaration-of-Interest_Behavioural-Science-Working-Group_Jeremy-Grimshaw_20210513.pdf)) He is also a member of the Canadian secretariat.((//Secretariat.// (2021). McMaster Health Forum. https://www.mcmasterforum.org/networks/covid-end/resources-specific-to-canada/about-us/secretariat))
+Grimshaw is a co-founder of the [[Behavioural, Environmental, Social and System Interventions Collaboration]] (BESSI), "which aims to promote research into BESSIs to reduce transmission and mitigate the effects of the pandemic."((//About | Behavioural, Environmental, Social and Systems Interventions.//  BESSI-Collab. Retrieved May 8, 2022, from https://www.bessi-collab.net/about-us))
+Grimshaw is a co-investigator for the [[Coronavirus Variants Rapid Response Network]] (CoVaRR-Net), funded by the [[Canadian Institutes of Health Research]] (CIHR).((//Our Team.// CoVaRR-Net. Retrieved May 8, 2022, from https://archive.ph/EWWMo))
+==== Vaccine hesitancy ====
+Grimshaw received funding from the [[Public Health Agency of Canada]] (PHAC) for a study on [[vaccine hesitancy]] related to [[COVID-19 vaccines]].((Crawshaw, J., Konnyu, K., Castillo, G., Zack Van Allen, Mba, M., Grimshaw, J., & Presseau, J. (2021). //Factors affecting COVID-19 vaccination acceptance and uptake among the general public: a living behavioural science evidence synthesis.// McMaster University Health Forum. https://web.archive.org/web/20220509061411/https://www.mcmasterforum.org/docs/default-source/product-documents/living-evidence-syntheses/covid-19-living-evidence-synthesis-4.1---factors-affecting-covid-19-vaccination-acceptance-and-uptake-among-the-general-public.pdf?sfvrsn=5368712f_7))
 ==== Diabetes ====
-Grimshaw received an operating grant as a co-Principal Investigator for a study called "An implementation
+Grimshaw received an operating grant from as a co-Principal Investigator from [[Diabetes Action Canada]] for a study called "An implementation
-science approach to increase attendance to retinopathy screening by people with [[diabetes]]."((Grimshaw, J. (2021). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://web.archive.org/web/20220508082748/https://covid19-sciencetable.ca/wp-content/uploads/2021/02/Declaration-of-Interest_Behavioural-Science-Working-Group_Jeremy-Grimshaw_20210513.pdf))
+science approach to increase attendance to retinopathy screening by people with [[diabetes]]."((Grimshaw, J. (2021). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://web.archive.org/web/20220508082748/https://covid19-sciencetable.ca/wp-content/uploads/2021/02/Declaration-of-Interest_Behavioural-Science-Working-Group_Jeremy-Grimshaw_20210513.pdf)) DAC is funded by [[pharmaceutical_companies:AstraZeneca]], [[pharmaceutical_companies:Bayer]], [[pharmaceutical_companies:Merck]] and [[Sun Life Financial]].((//Strategic Partners.// Diabetes Action Canada - SPOR Network. Retrieved May 8, 2022, from https://archive.ph/upCkV))
+==== Antimicrobial Resistance ====
+Grimshaw has published research on [[antimicrobial resistance]] with funding by the [[Joint Programming Initiative on Antimicrobial Resistance Network]] (JPIARN).((Rzewuska, M., Charani, E., Clarkson, J. E., Davey, P. G., Duncan, E. M., Francis, J. J., Gillies, K., Kern, W. V., Lorencatto, F., Marwick, C. A., McEwen, J., Möhler, R., Morris, A. M., Ramsay, C. R., Rogers Van Katwyk, S., Skodvin, B., Smith, I., Suh, K. N., & Grimshaw, J. M. (2019). //Prioritizing research areas for antibiotic stewardship programmes in hospitals: a behavioural perspective consensus paper.// Clinical Microbiology and Infection, 25(2), 163–168. https://doi.org/10.1016/j.cmi.2018.08.020))
 ==== Awards and Recognition ====
 Grimshaw was recognized as a [[Thomson Reuters]] Highly Cited Researcher in 2015, 2016 2017 and 2018.((//ICES scientists Peter Austin and Jeremy Grimshaw selected as 2016 Thomson Reuters Highly Cited Researchers.// (2016, November 18). ICES. https://archive.ph/ieRPL)) ((Grimshaw, J. M. (2019, June 3). //Curriculum Vitae.// McMaster University Health Forum. https://web.archive.org/web/20220509011301/https://www.mcmasterforum.org/docs/default-source/people-cv/grimshaw-cv.pdf?sfvrsn=53d154d5_3))